Galectin-1-binding glycoforms of haptoglobin with altered intracellular trafficking, and increase in metastatic breast cancer patients

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Carlsson, Michael C ^a   Cederfur, Cecilia ^a   Schaar, Viveka ^a   Balog, Crina I A ^b   Lepur, Adriana ^a   Touret, Franck ^a   Salomonsson, Emma ^a   Deelder, André M ^b   Fernö, Mårten ^c   Olsson, Håkan ^c   Wuhrer, Manfred ^b   Leffler, Hakon ^a  

^a LUND UNIVERSITY   (Sweden)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 MACROGLOBULIN; GALECTIN 1; GLYCAN; HAPTOGLOBIN; HEMOGLOBIN; IMMUNOGLOBULIN M; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; IMMOBILIZED PROTEIN; N ACETYLNEURAMINIC ACID; POLYSACCHARIDE;

ADULT; AFFINITY CHROMATOGRAPHY; ARTICLE; BINDING SITE; BREAST CANCER; COMPLEX FORMATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; INTRACELLULAR TRANSPORT; LYSOSOME; MACROPHAGE; MASS SPECTROMETRY; METASTASIS POTENTIAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN TARGETING; PROTEIN TRANSPORT; SEPARATION TECHNIQUE; AGED; BREAST TUMOR; CASE CONTROL STUDY; CHEMICAL STRUCTURE; CHEMISTRY; CYTOLOGY; ENDOCYTOSIS; ENZYME SPECIFICITY; IMMUNOLOGY; INTRACELLULAR SPACE; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; PROTEIN MULTIMERIZATION; PROTEIN QUATERNARY STRUCTURE; TUMOR CELL LINE;

AGED; BINDING SITES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CELL LINE, TUMOR; ENDOCYTOSIS; FEMALE; GALECTIN 1; HAPTOGLOBINS; HUMANS; IMMOBILIZED PROTEINS; IMMUNOGLOBULIN M; INTRACELLULAR SPACE; MACROPHAGES; MIDDLE AGED; MODELS, MOLECULAR; N-ACETYLNEURAMINIC ACID; NEOPLASM METASTASIS; POLYSACCHARIDES; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY; PROTEIN TRANSPORT; SUBSTRATE SPECIFICITY;

EID: 80054728440     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026560     Document Type: Article

References (65)

1. Polticelli F, Bocedi A, Minervini G, Ascenzi P, (2008) Human haptoglobin structure and function-a molecular modelling study. The FEBS journal 275: 5648-5656.
2. Miyoshi E, Nakano M, (2008) Fucosylated haptoglobin is a novel marker for pancreatic cancer: detailed analyses of oligosaccharide structures. Proteomics 8: 3257-3262.
3. Park SY, Yoon SJ, Jeong YT, Kim JM, Kim JY, et al. (2010) N-glycosylation status of beta-haptoglobin in sera of patients with colon cancer, chronic inflammatory diseases and normal subjects. Int J Cancer 126: 142-155.
4. Gornik O, Wagner J, Pucic M, Knezevic A, Redzic I, et al. (2009) Stability of N-glycan profiles in human plasma. Glycobiology 19: 1547-1553.
5. Pucic M, Pinto S, Novokmet M, Knezevic A, Gornik O, et al. (2010) Common aberrations from the normal human plasma N-glycan profile. Glycobiology 20: 970-975.
6. Lau KS, Partridge EA, Grigorian A, Silvescu CI, Reinhold VN, et al. (2007) Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation. Cell 129: 123-134.
7. Hakomori S, Handa K, (2002) Glycosphingolipid-dependent cross-talk between glycosynapses interfacing tumor cells with their host cells: essential basis to define tumor malignancy. FEBS Lett 531: 88-92.
8. Drake PM, Cho W, Li B, Prakobphol A, Johansen E, et al. (2010) Sweetening the pot: adding glycosylation to the biomarker discovery equation. Clin Chem 56: 223-236.
9. Arnold JN, Saldova R, Galligan MC, Murphy TB, Mimura-Kimura Y, et al. (2011) Novel glycan biomarkers for the detection of lung cancer. J Proteome Res 10: 1755-1764.
10. Cazet A, Julien S, Bobowski M, Burchell J, Delannoy P, (2010) Tumour-associated carbohydrate antigens in breast cancer. Breast Cancer Res 12: 204.
11. Dabelsteen E, (1996) Cell surface carbohydrates as prognostic markers in human carcinomas. J Pathol 179: 358-369.
12. Ohyama C, Hosono M, Nitta K, Oh-eda M, Yoshikawa K, et al. (2004) Carbohydrate structure and differential binding of prostate specific antigen to Maackia amurensis lectin between prostate cancer and benign prostate hypertrophy. Glycobiology 14: 671-679.
13. Meezan E, Wu HC, Black PH, Robbins PW, (1969) Comparative studies on the carbohydrate-containing membrane components of normal and virus-transformed mouse fibroblasts. II. Separation of glycoproteins and glycopeptides by sephadex chromatography. Biochemistry 8: 2518-2524.
14. Yamashita K, Koide N, Endo T, Iwaki Y, Kobata A, (1989) Altered glycosylation of serum transferrin of patients with hepatocellular carcinoma. J Biol Chem 264: 2415-2423.
15. Abd Hamid UM, Royle L, Saldova R, Radcliffe CM, Harvey DJ, et al. (2008) A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression. Glycobiology 18: 1105-1118.
16. Kannagi R, Yin J, Miyazaki K, Izawa M, (2008) Current relevance of incomplete synthesis and neo-synthesis for cancer-associated alteration of carbohydrate determinants-Hakomori's concepts revisited. Biochim Biophys Acta 1780: 525-531.
17. Dennis JW, Lau KS, Demetriou M, Nabi IR, (2009) Adaptive regulation at the cell surface by N-glycosylation. Traffic 10: 1569-1578.
18. Fortin S, Le Mercier M, Camby I, Spiegl-Kreinecker S, Berger W, et al. (2010) Galectin-1 is implicated in the protein kinase C epsilon/vimentin-controlled trafficking of integrin-beta1 in glioblastoma cells. Brain pathology 20: 39-49.
19. Huang CL, Moe OW, (2011) Klotho: a novel regulator of calcium and phosphorus homeostasis. Pflugers Archiv: European journal of physiology.
20. Leffler H, Carlsson S, Hedlund M, Qian Y, Poirier F, (2004) Introduction to galectins. Glycoconj J 19: 433-440.
21. Yang RY, Rabinovich GA, Liu FT, (2008) Galectins: structure, function and therapeutic potential. Expert reviews in molecular medicine 10: e17.
22. Liu FT, Rabinovich GA, (2005) Galectins as modulators of tumour progression. Nat Rev Cancer 5: 29-41.
23. Liu FT, Rabinovich GA, (2010) Galectins: regulators of acute and chronic inflammation. Annals of the New York Academy of Sciences 1183: 158-182.
24. Rabinovich GA, Toscano MA, (2009) Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation. Nature reviews Immunology 9: 338-352.
25. Cederfur C, Salomonsson E, Nilsson J, Halim A, Oberg CT, et al. (2008) Different affinity of galectins for human serum glycoproteins: galectin-3 binds many protease inhibitors and acute phase proteins. Glycobiology 18: 384-394.
26. Carlsson A, Wingren C, Ingvarsson J, Ellmark P, Baldertorp B, et al. (2008) Serum proteome profiling of metastatic breast cancer using recombinant antibody microarrays. Eur J Cancer 44: 472-480.
27. Hirabayashi J, Hashidate T, Arata Y, Nishi N, Nakamura T, et al. (2002) Oligosaccharide specificity of galectins: a search by frontal affinity chromatography. Biochim Biophys Acta 1572: 232-254.
28. Salomonsson E, Larumbe A, Tejler J, Tullberg E, Rydberg H, et al. (2010) Monovalent Interactions of Galectin-1. Biochemistry 49: 9518-9532.
29. Ceroni A, Maass K, Geyer H, Geyer R, Dell A, et al. (2008) GlycoWorkbench: a tool for the computer-assisted annotation of mass spectra of glycans. J Proteome Res 7: 1650-1659.
30. Steen H, Pandey A, Andersen JS, Mann M, (2002) Analysis of tyrosine phosphorylation sites in signaling molecules by a phosphotyrosine-specific immonium ion scanning method. Sci STKE 2002: pl16.
31. Nishi N, Abe A, Iwaki J, Yoshida H, Itoh A, et al. (2008) Functional and structural bases of a cysteine-less mutant as a long-lasting substitute for galectin-1. Glycobiology 18: 1065-1073.
32. Langlois MR, Delanghe JR, (1996) Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 42: 1589-1600.
33. Harazono A, Kawasaki N, Itoh S, Hashii N, Matsuishi-Nakajima Y, et al. (2008) Simultaneous glycosylation analysis of human serum glycoproteins by high-performance liquid chromatography/tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 869: 20-30.
34. Dam TK, Gabius HJ, Andre S, Kaltner H, Lensch M, et al. (2005) Galectins bind to the multivalent glycoprotein asialofetuin with enhanced affinities and a gradient of decreasing binding constants. Biochemistry 44: 12564-12571.
35. Stowell SR, Arthur CM, Mehta P, Slanina KA, Blixt O, et al. (2008) Galectin-1,-2, and-3 exhibit differential recognition of sialylated glycans and blood group antigens. J Biol Chem 283: 10109-10123.
36. Allen HJ, Ahmed H, Matta KL, (1998) Binding of synthetic sulfated ligands by human splenic galectin 1, a beta-galactoside-binding lectin. Glycoconj J 15: 691-695.
37. Ferens-Sieczkowska M, Olczak M, (2001) Carbohydrate structures of haptoglobin in sera of healthy people and a patient with congenital disorder of glycosylation. Z Naturforsch C 56: 122-131.
38. Tsai CM, Guan CH, Hsieh HW, Hsu TL, Tu Z, et al. (2011) Galectin-1 and Galectin-8 Have Redundant Roles in Promoting Plasma Cell Formation. J Immunol 187: 1643-1652.
39. Leppanen A, Stowell S, Blixt O, Cummings RD, (2005) Dimeric galectin-1 binds with high affinity to alpha2,3-sialylated and non-sialylated terminal N-acetyllactosamine units on surface-bound extended glycans. J Biol Chem 280: 5549-5562.
40. Stowell SR, Dias-Baruffi M, Penttila L, Renkonen O, Nyame AK, et al. (2004) Human galectin-1 recognition of poly-N-acetyllactosamine and chimeric polysaccharides. Glycobiology 14: 157-167.
41. Song X, Xia B, Stowell SR, Lasanajak Y, Smith DF, et al. (2009) Novel fluorescent glycan microarray strategy reveals ligands for galectins. Chem Biol 16: 36-47.
42. Saussez S, Lorfevre F, Lequeux T, Laurent G, Chantrain G, et al. (2008) The determination of the levels of circulating galectin-1 and-3 in HNSCC patients could be used to monitor tumor progression and/or responses to therapy. Oral Oncol 44: 86-93.
43. Madsen M, Graversen JH, Moestrup SK, (2001) Haptoglobin and CD163: captor and receptor gating hemoglobin to macrophage lysosomes. Redox Rep 6: 386-388.
44. Graversen JH, Madsen M, Moestrup SK, (2002) CD163: a signal receptor scavenging haptoglobin-hemoglobin complexes from plasma. Int J Biochem Cell Biol 34: 309-314.
45. Xu W, Schlagwein N, Roos A, van den Berg TK, Daha MR, et al. (2007) Human peritoneal macrophages show functional characteristics of M-CSF-driven anti-inflammatory type 2 macrophages. Eur J Immunol 37: 1594-1599.
46. Kovtunovych G, Eckhaus MA, Ghosh MC, Ollivierre-Wilson H, Rouault TA, (2010) Dysfunction of the heme recycling system in heme oxygenase 1 deficient mice: effects on macrophage viability and tissue iron distribution. Blood 116: 6054-6062.
47. MacKinnon AC, Farnworth SL, Hodkinson PS, Henderson NC, Atkinson KM, et al. (2008) Regulation of alternative macrophage activation by galectin-3. Journal of immunology 180: 2650-2658.
48. Fajka-Boja R, Blasko A, Kovacs-Solyom F, Szebeni GJ, Toth GK, et al. (2008) Co-localization of galectin-1 with GM1 ganglioside in the course of its clathrin- and raft-dependent endocytosis. Cell Mol Life Sci 65: 2586-2593.
49. Heuser J, (1989) Changes in lysosome shape and distribution correlated with changes in cytoplasmic pH. J Cell Biol 108: 855-864.
50. Zinchuk V, Zinchuk O, Okada T, (2007) Quantitative colocalization analysis of multicolor confocal immunofluorescence microscopy images: pushing pixels to explore biological phenomena. Acta Histochem Cytochem 40: 101-111.
51. Bresalier RS, Byrd JC, Tessler D, Lebel J, Koomen J, et al. (2004) A circulating ligand for galectin-3 is a haptoglobin-related glycoprotein elevated in individuals with colon cancer. Gastroenterology 127: 741-748.
52. Arnold JN, Wormald MR, Suter DM, Radcliffe CM, Harvey DJ, et al. (2005) Human serum IgM glycosylation: identification of glycoforms that can bind to mannan-binding lectin. J Biol Chem 280: 29080-29087.
53. Arnold JN, Wallis R, Willis AC, Harvey DJ, Royle L, et al. (2006) Interaction of mannan binding lectin with alpha2 macroglobulin via exposed oligomannose glycans: a conserved feature of the thiol ester protein family? J Biol Chem 281: 6955-6963.
54. Taniuchi K, Cerny RL, Tanouchi A, Kohno K, Kotani N, et al. (2011) Overexpression of GalNAc-transferase GalNAc-T3 promotes pancreatic cancer cell growth. Oncogene.
55. Sparrow CP, Leffler H, Barondes SH, (1987) Multiple soluble beta-galactoside-binding lectins from human lung. J Biol Chem 262: 7383-7390.
56. Puig-Kroger A, Sierra-Filardi E, Dominguez-Soto A, Samaniego R, Corcuera MT, et al. (2009) Folate receptor beta is expressed by tumor-associated macrophages and constitutes a marker for M2 anti-inflammatory/regulatory macrophages. Cancer Res 69: 9395-9403.
57. Gordon S, (2003) Alternative activation of macrophages. Nat Rev Immunol 3: 23-35.
58. Cid MC, Grant DS, Hoffman GS, Auerbach R, Fauci AS, et al. (1993) Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis. J Clin Invest 91: 977-985.
59. Lauc G, Essafi A, Huffman JE, Hayward C, Knezevic A, et al. (2010) Genomics meets glycomics-the first GWAS study of human N-Glycome identifies HNF1alpha as a master regulator of plasma protein fucosylation. PLoS genetics 6: e1001256.
60. Fujita T, Murayama K, Hanamura T, Okada T, Ito T, et al. (2011) CSLEX (Sialyl Lewis X) is a useful tumor marker for monitoring of breast cancer patients. Jpn J Clin Oncol 41: 394-399.
61. Grassadonia A, Tinari N, Iurisci I, Piccolo E, Cumashi A, et al. (2004) 90K (Mac-2 BP) and galectins in tumor progression and metastasis. Glycoconj J 19: 551-556.
62. Thompson IM, Ankerst DP, (2007) Prostate-specific antigen in the early detection of prostate cancer. CMAJ 176: 1853-1858.
63. Holmstrom B, Johansson M, Bergh A, Stenman UH, Hallmans G, et al. (2009) Prostate specific antigen for early detection of prostate cancer: longitudinal study. BMJ 339: b3537.
64. Arnold JN, Saldova R, Hamid UM, Rudd PM, (2008) Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation. Proteomics 8: 3284-3293.
65. Nielsen MJ, Petersen SV, Jacobsen C, Thirup S, Enghild JJ, et al. (2007) A unique loop extension in the serine protease domain of haptoglobin is essential for CD163 recognition of the haptoglobin-hemoglobin complex. J Biol Chem 282: 1072-1079.